Axis Arçelik

Suphi güray sirli january 13 2019.
Axis arçelik. The categories reflect the relationship between an innovation s technological readiness and the commitment of its innovators in terms of innovation management. Axis avm arçelik bayi. Arcelik does not right now have any fundamental measures for analysis. 212 likes 2 were here.
Alacağıma karar verip gittiğim için. Arcelik financial statements provide useful quarterly and yearly information to potential arcelik investors about the current and past financial position of the company as well as its overall management performance and changes in financial position over time. Avm nin kötü ve tercih edilmediğinden buraya alışverişe sakin olduğu için gidiyorum. Arcelik otc stock forecast is based on your current time horizon.
Most of arcelik s fundamental indicators such as number of employees are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. However solely looking at the historical price movement is usually misleading. Put another way 15 of traded otc stocks are less volatile than arcelik and 96 of all traded equity. If the real value is higher than the market price arcelik is considered to be undervalued and we provide a buy recommendation.
Investors can use this forecasting interface to forecast arcelik historical stock prices and determine the direction of arcelik s future trends based on various well known forecasting models. Outstanding shares are typically reported on fully diluted bases including exotic instruments such as options or convertibles bonds. Given the covid 19 pandemic call ahead to verify hours and remember to practice social distancing. 1 tip and review.
If you would invest 1 196 in arcelik on august 10 2020 and sell it today you would earn a total of 194 00 from holding arcelik or generate 16 22 return on investment over 30 days. Arcelik shares outstanding is currently at 135 15 m. Axis avm arçelik yetkili bayisidir. Outstanding shares are shares of common stock of a public arcelik that were purchased by investors after they were authorized and issued by the arcelik to the public.
Arcelik is currently producing 0 254 returns and takes up 1 745 volatility of returns over 30 trading days.